Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2025-12-25 @ 8:05 PM
Study NCT ID:
NCT02979535
Status:
COMPLETED
Last Update Posted:
2022-03-25
First Post:
2016-11-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-25
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-29
First Submit QC Date:
None
Study First Post Date:
2016-12-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-02-21
Results First Submit QC Date:
None
Results First Post Date:
2020-03-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-15
Last Update Post Date:
2022-03-25
Last Update Post Date Type:
ACTUAL